Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes
Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

Alzamend Neuro Sets Stage for Phase II Clinical Trial of AL001 Targeting Post-Traumatic Stress Disorder at Massachusetts General Hospital

Mar 13, 2025 (PRISM News via COMTEX) --
Alzamend Neuro, Inc. (Nasdaq: ALZN), a forward-thinking clinical-stage biopharmaceutical entity, is gearing up to launch a pivotal Phase II clinical trial of its innovative treatment,...

The post Alzamend Neuro Sets Stage for Phase II Clinical Trial of AL001 Targeting Post-Traumatic Stress Disorder at Massachusetts General Hospital appeared first on PRISM MarketView.

comtex tracking

COMTEX_463575280/2927/2025-03-13T12:10:50
Privacy statement Futures charts and quotes Forex charts and quotes

Do not sell my personal information

Copyright © 2025. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.